Meanwhile, the proliferative potential, the self‐renewal ability, and CD44+ and CD133+ cells of primary CRC cells impaired by DCLK1 inhibitor, were rescued by exogenous expression β‐catenin (Figure S9B–D). Here, DCLK1 is linked to colorectal carcinoma.